From theheart.org on Medscape

Coverage from the

European Society of Cardiology (ESC) Congress 2019, World Congress of Cardiology

August 31 - September 04, 2019; Paris, France

August 31 - September 04, 2019 Paris, France

Meeting Highlights At A Glance

Top News From ESC 2019: Slideshow Headlines from the world's largest cardiology meeting include a new approach to heart failure and reduced ejection fraction and counterintuitive findings on antiplatelet therapy for acute coronary syndrome.

Conference News

ESC 2019 ENTRUST-AF PCI Supports Safety of Dual Therapy With Edoxaban
Medscape Medical News, September 19, 2019
ESC 2019 Small Prolonged Reductions in LDL, BP Substantially Reduce CV Risk
Medscape Medical News, September 17, 2019
ESC 2019 ESC Offers Updated Guidance on Acute Pulmonary Embolism
Medscape Medical News, September 13, 2019
ESC 2019 Bariatric Surgery Tied to Less MACE in Obesity, Diabetes
Medscape Medical News, September 13, 2019
ESC 2019 Long-Term Beta Blockers Post-CABG Questioned, Even With Low LVEF
Medscape Medical News, September 12, 2019
ESC 2019 Cardiac 'Shrinkage' on Sacubitril/Valsartan May Rival CRT in HF
Medscape Medical News, September 11, 2019
ESC 2019 ORION-11: 50% Reduction in LDL With Twice-Yearly Injection
Medscape Medical News, September 11, 2019
ESC 2019 Remote Ischemic Conditioning Fails in MI: CONDI-2/ERIC-PPCI
Medscape Medical News, September 10, 2019
ESC 2019 RAPID-TnT Supports 0/1-Hour Troponin T protocol, but With a Wrinkle
Medscape Medical News, September 6, 2019
ESC 2019 HOPE 4: Hypertension Screening in Community Reduces CV Risk
Medscape Medical News, September 6, 2019
ESC 2019 AI Could Slash Diagnosis Costs in Stable Chest Pain Patients
Medscape News UK, September 6, 2019
ESC 2019 Risk Score Reveals Nonvascular Factors Linked to GI Bleed
Medscape News UK, September 5, 2019
ESC 2019 Vintage ICD Trials in Heart Failure Upheld by Contemporary Data
Medscape Medical News, September 4, 2019
ESC 2019 HiSTORIC Validates High-Sensitivity Troponin Test to Rule Out MI
Medscape Medical News, September 4, 2019
ESC 2019 SYNTAXES: CABG for Best 10-Year Survival in Multivessel Disease
Medscape Medical News, September 4, 2019
ESC 2019 DAPA: Early ICD After Primary PCI-Treated STEMI Saves Lives
Medscape Medical News, September 4, 2019
ESC 2019 MITRA-FR at 2 Years: MitraClip Still No Better Than Med Therapy
Medscape Medical News, September 3, 2019
ESC 2019 Genetic Testing Spots Clopidogrel Responders After PCI for STEMI
Medscape Medical News, September 3, 2019

ESC 2019 Text Messages Improve Blood Glucose Control in Diabetes
Medscape Medical News, September 3, 2019
ESC 2019 Oxygen in Suspected ACS May Benefit Those With Low Levels
Medscape Medical News, September 3, 2019
ESC 2019 Cancer Overtakes CVD as Leading Cause of Death in Wealthy Nations
Medscape Medical News, September 3, 2019
ESC 2019 AFIRE Backs Less Antiplatelet Use With NOAC in AF, Stable CAD
Medscape Medical News, September 2, 2019
ESC 2019 DANAMI-2: PCI Still Beats Lysis in STEMI Even 16 Years On
Medscape Medical News, September 2, 2019
ESC 2019 Community-Wide Salt Swap Moves BP Needle, Halves Hypertension
Medscape Medical News, September 2, 2019
ESC 2019 ESC Diabetes and CVD Guideline: 'Unprecedented' New Evidence
Medscape Medical News, September 2, 2019
ESC 2019 New ESC Guideline on SVT Management: Catheter Ablation Key
Medscape Medical News, September 2, 2019
ESC 2019 ISAR-REACT 5: Prasugrel Bests Ticagrelor in ACS
Medscape Medical News, September 2, 2019
ESC 2019 Dapagliflozin: New HF Therapy, Even Sans Diabetes
Medscape Medical News, September 1, 2019
ESC 2019 PARAGON-HF: Sacubitril/Valsartan Frustrates in Preserved-EF HF
Medscape Medical News, September 1, 2019
ESC 2019 THEMIS: A Role for Ticagrelor in Diabetic Patients With Prior PCI?
Medscape Medical News, September 1, 2019
ESC 2019 COMPLETE: Better Outcome With PCI in Nonculprit Lesions After STEMI
Medscape Medical News, September 1, 2019
ESC 2019 Stable CAD Reconsidered: ESC Chronic Coronary Syndrome Guideline
Medscape Medical News, September 1, 2019
ESC 2019 New European Lipid Guidelines Take Aggressive Approach
Medscape Medical News, September 1, 2019
ESC 2019 Early Evolocumab in Acute Coronary Syndrome Safe, LDL Plummets
Medscape Medical News, August 31, 2019
ESC 2019 Bleeding in ACS Patients on DAPT Should Prompt Cancer Search
Medscape Medical News, August 31, 2019
ESC 2019 Paris, Clinical Trials Très Chic, New Guidelines: ESC Congress '19
Medscape Medical News, August 26, 2019

© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Perspectives

PROVE-HF Cracks the 'Holy Grail' of Cardiac Remodeling in HFrEF
Ileana L. Piña, MD, MPH; James L. Januzzi, MD
PARAGON-HF: Is There a Role for the ARNI in HFpEF?
Ileana L. Piña, MD, MPH; Burkert Pieske, MD
Debating ISAR-REACT 5: Ticagrelor vs Prasugrel in ACS
Robert F. Storey, BSc, BM, DM; Dirk Sibbing, MD, MHBA
High-Sensitivity Troponin Implementation: HiSTORIC in Practice
John M. Mandrola, MD; Nicholas L. Mills, MBBS
The Latest on MitraClip From ESC 2019
Prof Bernard Prendergast
ESC 2019: Which Trials Could Change Cardiology Practice?
Mamas A. Mamas, BM, BCh, MA, DPhil, FRCP
Salt and CVD Controversies: What’s Shaking?
Bruce Neal MB ChB, PhD; Michel Burnier, MD

Bloggers from the Floor

Will DAPA-HF Turn the Tide on Heart Failure? The term gamechanger is overused but may be appropriate for the DAPA-HF trial on the SGLT2 inhibitor dapagliflozin in patients with heart failure and reduced ejection fraction. Medical conservative John Mandrola, MD, was impressed.
When Guideline Authors Dismiss Important Studies Why does a guideline document on chronic coronary disease exclude the landmark ORBITA trial? Perhaps it's an existential tension, suggests John Mandrola, MD.
PARAGON-HF: Heart Failure With Preserved EF Proves a Tough Foe Given the few effective therapies for HFpEF, should a new expensive drug be adopted on the basis of a borderline clinical trial result? John Mandrola, MD, weighs in.
Mandrola Previews ESC 2019 Read what John Mandrola, MD, is looking forward to in Paris. Despite some advance spoilers, there will be plenty to pique the interest of the average cardiologist.

Millennial Mentoring: Is it Time to Soften Our Rough Edges? Mellissa Walton-Shirley attended a talk on workplace challenges from a millennial physician, which made her rethink her assessment of a former intern as 'smart but lazy.'
Cardiologists Should Prescribe SGLT2 Inhibitors Is it fair to expect cardiologists to now prescribe the new diabetes drugs? Presentations at the European Society of Cardiology Congress prove persuasive to Melissa Walton-Shirley, MD.

Popular News from ESC 2018

Daily Aspirin Fails as Primary Prevention in ARRIVE Trial Its low-risk patients also had access to great CV therapies. 'Once you've dealt with the lipids, and once you've dealt with the hypertension, I'm really not sure what's left for aspirin,' said an observer.
Medscape Medical News, Aug 26, 2018
ASCEND: Aspirin Not Needed for Primary Prevention in Diabetes The benefit of aspirin on reducing vascular events did not outweigh the increased risk for serious bleeding in this new large primary prevention trial in diabetic patients.
Medscape Medical News, Aug 27, 2018
Omega-3 Supplements: No Effect on Vascular Events in ASCEND The largest and longest placebo-controlled randomized trial of omega-3 fatty acid supplementation has found no effect on serious vascular events, cancer, or mortality.
Medscape Medical News, Aug 27, 2018

Previous Coverage

Related Resource